Sycamore Ventures is a private equity general partner firm with offices in Singapore and United States.
Amkey Ventures led a $20m Series A1 funding round for Apexigen, a biopharmaceutical company developing treatments for serious diseases.
Read more news concerning Sycamore Ventures
A sampling of Sycamore Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?